No abstract available
Keywords:
cancer; children; genetic; hematology; oncology; pediatric; predisposition; syndromes.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic New insights into cancer predisposition syndromes in pediatric hematology-oncology
References
-
-
Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. . Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. (2015) 373(24):2336–46. doi: 10.1056/NEJMoa1508054
-
DOI
-
PMC
-
PubMed
-
-
Baccelli F, Leardini D, Cerasi S, Messelodi D, Bertuccio SN, Masetti R. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. Ann Hematol. (2023) 102(4):699–705. doi: 10.1007/s00277-023-05128-2
-
DOI
-
PMC
-
PubMed
-
-
Bakhuizen JJ, Hopman SMJ, Bosscha MI, Dommering CJ, van den Heuvel-Eibrink MM, Hol JA, et al. . Assessment of cancer predisposition syndromes in a national cohort of children with a neoplasm. JAMA Netw Open. (2023) 6(2):e2254157. doi: 10.1001/jamanetworkopen.2022.54157
-
DOI
-
PMC
-
PubMed
-
-
Bruzzese A, Leardini D, Masetti R, Strocchio L, Girardi K, Algeri M, et al. . GATA2 related conditions and predisposition to pediatric myelodysplastic syndromes. Cancers (Basel). (2020) 12:2962. doi: 10.3390/cancers12102962
-
DOI
-
PMC
-
PubMed
-
-
Fabozzi F, Mastronuzzi A, Ceglie G, Masetti R, Leardini D. GATA 2 deficiency: focus on immune system impairment. Front Immunol. (2022) 13:865773. doi: 10.3389/fimmu.2022.865773
-
DOI
-
PMC
-
PubMed